Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk

BACKGROUND: Although ticagrelor is known to increase the bleeding risk compared to clopidogrel in East Asian patients, its clinical benefits in patients with acute myocardial infarction (AMI) without high bleeding risk (HBR) remains unknown. METHODS: A total of 7,348 patients who underwent successfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Keun-Ho, Jeong, Myung Ho, Kim, Hyun Kuk, Ki, Young-Jae, Kim, Sung Soo, Choi, Dong-Hyun, Koh, Young-Youp, Ahn, Youngkeun, Kim, Hyo-Soo, Gwon, Hyeon-Cheol, Rha, Seung-Woon, Hwang, Jin-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560314/
https://www.ncbi.nlm.nih.gov/pubmed/34725976
http://dx.doi.org/10.3346/jkms.2021.36.e268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560314/
https://www.ncbi.nlm.nih.gov/pubmed/34725976
http://dx.doi.org/10.3346/jkms.2021.36.e268

Ejemplares similares